A carregar...
PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections
Disease due to pulmonary Aspergillus infection remains a significant unmet need, particularly in immunocompromised patients, patients in critical care and those with underlying chronic lung diseases. To date, treatment using inhaled antifungal agents has been limited to repurposing available systemi...
Na minha lista:
| Publicado no: | J Fungi (Basel) |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7765807/ https://ncbi.nlm.nih.gov/pubmed/33348852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jof6040373 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|